- The Analysis of Thrombopoietin and Clinical Parameters as a Marker for Disease Progression in Patients with Multiple Myeloma
-
Lee JJ, Kang SY, Lee WI
- KMID: 1781599
- Korean J Lab Med.
- 2009 Feb;29(1):82-88.
- doi: 10.3343/kjlm.2009.29.1.82
BACKGROUND: Multiple myeloma (MM) causes the suppression of hematopoiesis because of malignant cells in the bone marrow. Thrombopoietin (TPO) is regulated by a feedback mechanism with platelets. Recently, it was... -
- CITED
-
- Close
- SHARE
-
- Close
